Related Experiment Video

Updated: Jun 6, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Ubiquitination-dependent regulation of signaling receptors in cancer

Wei-Chun Huangfu1, Serge Y Fuchs

  • 1Department of Animal Biology and Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Genes & Cancer
|December 4, 2010
PubMed

Insights

Ubiquitination of cell surface receptors controls cell sensitivity to external signals. Cancer cells exploit altered ubiquitination to promote tumor growth and survival.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Biochemistry

Background:

  • Ubiquitination of signaling cell surface receptors regulates cellular responses to extracellular signals.
  • This process impacts cell function, proliferation, and viability, influencing sensitivity to regulatory molecules.
  • Dysregulation of receptor ubiquitination and degradation is frequently observed in various cancers.

Purpose of the Study:

  • To discuss the mechanisms of signaling receptor ubiquitination in cancer.
  • To highlight the significance of these mechanisms in the context of cancer development and progression.
  • To explore the therapeutic implications of targeting receptor ubiquitination in human cancers.

Main Methods:

  • Literature review and synthesis of existing research on receptor ubiquitination.
  • Analysis of how cancer cells modify ubiquitination pathways.
  • Discussion of the role of ubiquitination in cancer signaling.

Main Results:

  • Signaling receptor ubiquitination is a critical regulator of cellular sensitivity to external stimuli.
  • Cancer cells adapt receptor ubiquitination to favor pathways that support tumor growth and survival.
  • Altered ubiquitination can either enhance or suppress signaling pathways depending on the tumor's needs.

Conclusions:

  • Receptor ubiquitination plays a pivotal role in cancer biology by modulating signaling pathways.
  • Targeting ubiquitination mechanisms offers potential therapeutic strategies for cancer treatment.
  • Understanding these pathways is crucial for developing novel anti-cancer therapies.
Keywords:
E3 ligasecancerkinasereceptorsignal transductionubiquitin

More Related Videos

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations10:26

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Published on: November 7, 2019

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...